<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33507093</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>5-6</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS).</ArticleTitle><Pagination><StartPage>350</StartPage><EndPage>359</EndPage><MedlinePgn>350-359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1874991</ELocationID><Abstract><AbstractText>The aim of this study was to investigate how nutritional management services for people with Amyotrophic Lateral Sclerosis (pwALS) are structured in the UK, in order to gain insight into current practice and identify key barriers and enablers to delivering and providing services. <i>Methods</i>: A three-part, sequential mixed-methods study was conducted that comprised (i) a thematic analysis of data from five focus groups (with 47 ALS health professionals from 41 UK organizations and four service user representatives), (ii) a nationwide cross-sectional survey (281 ALS healthcare professionals) and (iii) a freedom of information request (251 organizations). <i>Results</i>: UK nutritional management services for pwALS are coordinated from specialist (<i>n</i>&#x2009;=&#x2009;22) and non-specialist care centers (<i>n</i>&#x2009;=&#x2009;89), with national variability in the organization and delivery of services. Multidisciplinary working was highlighted to facilitate the coordination of nutritional care. However, the need to provide evidence-based continuing education for HCPs was evident. Overall, the lack of clear guidelines on the nutritional management of people with ALS was identified as a key barrier to the delivery of effective nutritional care, as was the lack of transparency and consistency in the commissioning of nutritional services. Further concerns over the timeliness of the dietetic intervention and equity of access and provision were raised. <i>Conclusions</i>: Our findings suggest that development of guidelines for nutritional management, particularly at diagnosis and pre-gastrostomy, could drive standardization of high quality nutritional care for pwALS. Such guidance has the potential to reduce inequalities in geographical provision by providing clarity for those commissioning specialist nutrition services.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarotti</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8129-6151</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coates</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGeachan</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Psychology, The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beever</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychology, The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hackney</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezaydi</LastName><ForeName>Naseeb</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavroulakis</LastName><ForeName>Theocharis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradburn</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDermott</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1269-9053</Identifier><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP-PG-1016-20006</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018529" MajorTopicYN="Y">Nutritional Support</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nutrition management</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">health services</Keyword><Keyword MajorTopicYN="N">mixed methods</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33507093</ArticleId><ArticleId IdType="pmc">PMC8312499</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1874991</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marin B, Arcuti S, Jesus P, Logroscino G, Copetti M, Fontana A, French register of ALS in Limousin (FRALim), et al.. Population-based evidence that survival in amyotrophic lateral sclerosis is related to weight loss at diagnosis neurodegenerative. Neurodegener Dis. 2016;16:225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26866503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning P, Yang B, Li S, Mu X, Shen Q, Hu F, et al. . Systematic review of the prognostic role of body mass index in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener.2019;20:356&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">30931632</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, et al. . Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol. 2019;266:1412&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">30868220</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner S, Hendricks M, Kollewe K, Zapf A, Dengler R, Silani V, et al. . Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3717067</ArticleId><ArticleId IdType="pubmed">23848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Ren&#xe9; F, Gonzalez de Aguilar J-L, Loeffler J-P.. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA. 2004;101:11159&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Ficano L, Piccoli F, La Bella V.. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;304:44&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21371720</ArticleId></ArticleIdList></Reference><Reference><Citation>, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al.. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Quality Standards Subcommittee of the American Academy of Neurology, et al.. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1227&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764728</ArticleId><ArticleId IdType="pubmed">19822873</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. . Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227612</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . Nutrition support in adults: oral nutrition support, enteral tube feeding and parenteral nutrition 2006.  [online]. Available at: https://www.nice.org.uk/guidance/cg32. Accessed October 2019.</Citation></Reference><Reference><Citation>O'Brien MR. Healthcare professionals' knowledge of motor neurone disease. Br J Nurs. 2004;13:1080&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">15564993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rio A, Cawadias E.. Nutritional advice and treatment by dietitians to patients with amyotrophic lateral sclerosis/motor neurone disease: a survey of current practice in England, Wales, Northern Ireland and Canada. J Hum Nutr Diet. 2007;20:3&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17241187</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Hubbard J, Rudnicki SA, Johansen CS, Dalton K, Heiman-Patterson T, et al. . Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis. Espen J. 2013;8:e25&#x2013;e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283833</ArticleId><ArticleId IdType="pubmed">25568837</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . Motor neurone disease: assessment and management. 2016.  [online]. Available at: https://www.nice.org.uk/guidance/ng42. Accessed September 2020.</Citation></Reference><Reference><Citation>Medical Research Council  A framework for development and evaluation of RCTs for complex interventions to improve health. 2000.  [online]. Available at https://mrc.ukri.org/documents/pdf/rcts-for-complex-interventions-to-improve-health/. Accessed September 2020.</Citation></Reference><Reference><Citation>O'Cathain A, Murphy E, Nicholl J.. Three techniques for integrating data in mixed methods studies. BMJ. 2010;341:c4587&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">20851841</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V.. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77&#x2013;101.</Citation></Reference><Reference><Citation>Zarotti N, Coates E, McGeachan Williams I, Beever D, Hackney G, Norman P, on behalf of the HighCALS Study Group, et al.. Health care professionals' views on psychological factors affecting nutritional behaviour in people with motor neuron disease: a thematic analysis. Br J Health Psychol. 2019;24:953&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">31449739</ArticleId></ArticleIdList></Reference><Reference><Citation>Aridegbe T, Kandler R, Walters S, Walsh T, Shaw P, McDermott C.. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener.2013;14:13&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22642305</ArticleId></ArticleIdList></Reference><Reference><Citation>White S, Zarotti N, Beever D, Bradburn M, Norman P, Coates E, et al. , on behalf of the HighCALS Study Group. The nutritional management of people living with amyotrophic lateral sclerosis (ALS): a national survey of dietitians. n.d. (under review).</Citation><ArticleIdList><ArticleId IdType="pubmed">33786908</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, et al. . multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry. 2015;86:496&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">25550416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden A, Foley G, Henderson R, James N, Aoun SM.. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:205&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446964</ArticleId><ArticleId IdType="pubmed">28579792</ArticleId></ArticleIdList></Reference><Reference><Citation>MNDA, MS Trust and Parkinson&#x2019;s UK . Allied health professionals competency framework for progressive neurological conditions. 2018.  [online]. Available at: https://www.mndassociation.org/allied-health-professionals-competency-framework/. Accessed September 2020.</Citation></Reference><Reference><Citation>Bloem BR, Dorsey ER, Okun MS.. The Coronavirus disease 2019 crisis as catalyst for telemedicine for chronic neurological disorders. JAMA Neurol. 2020;77:927&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329796</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>